Angiogenesis is a crucial step in many pathological conditions like cancer, inflammation and metastasis formation; on these basis the search for antiangiogenic agents has widened. In order to identify new compounds able to interfere in the Vascular Endothelial Growth Factor Receptor-1 (VEGFR-1, also known as Flt-1) recognition by VEGFs family members, we screened Calycolpus moritzianus (O. Berg) Burret leaves extracts by a competitive ELISA-based assay. MeOH and CHCl3 extracts and several their fractions demonstrated to be able to prevent VEGF or PlGF interaction with Flt-1, with an inhibition about 50% at concentration of 100 μg/mL. Phytochemical and pharmacological investigation of the active fractions led to the isolation of flavonoids, and terpenes.
CarmelietP., JainR.K. (2000) Angiogenesis in cancer and other diseases. Nature, 407, 249–257; (b) Carmeliet P. (2003) Angiogenesis in health and disease. Nature Medicine, 9, 653-660; (c) Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. (2000) Vascular-specific growth factors and blood vessel formation. Nature, 407, 242–248; (d) Carmeliet P. (2005) Angiogenesis in life, disease and medicine. Nature, 438, 932–936. (e) D. Hanahan, J. Folkman. (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86, 353–364.
2.
LiekensS., De ClercqE., NeytsJ. (2001) Angiogenesis: regulators and clinical applications. Biochemical Pharmacology, 61, 253–270; (b) Luttun A, Tjwa M, Carmeliet P. (2002) Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): novel therapeutic targets for angiogenic disorders. Annals of the New York Academy of Sciences, 979, 80–93.
LogesS., SchmidtT., CarmelietP. (2009) Antimyeloangiogenic” therapy for cancer by inhibiting PlGF. Clinical Cancer Research, 15, 3648–3653.
5.
FischerC., MazzoneM., JonckxB., CarmelietP. (2008) FLT1 and its ligands VEGFB and PlGF: drug targets for antiangiogenic therapy?Nature Reviews Cancer, 8, 942–956. (b) Fischer C, Jonckx B, Mazzone M, Zacchigna S, Loges S, Pattarini L, Chorianopoulos E, Liesenborghs L, Koch M, De Mol M, Autiero M, Wyns S, Plaisance S, Moons L, van Rooijen N, Giacca M, Stassen JM, Dewerchin M, Collen D, Carmeliet P. (2007) Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels. Cell, 131, 463–475.
6.
LeporeL., MalafronteN., ConderoF.B., GualtieriM.J., AbdoS., Dal PiazF., De TommasiN. (2011) Isolation and structural characterization of glycosides from an antiangiogenic extract of Monnina obtusifolia H.B.K. Fitoterapia, 82, 178–183; (b) Ponticelli S, Braca A, De Tommasi N, De Falco S. (2008) Competitive ELISA-based screening of plant derivatives for the inhibition of VEGF family members interaction with vascular endothelial growth factor receptor 1. Planta Medica, 74, 401-406.
7.
BrahimL.F., El-SenousyW.M., HawasU.W. (2007) NMR spectral analysis of flavonoids from coronarium. Chemistry of Natural Compounds, 43, 659–662.
8.
LiM., HanX., YuB. (2003) Facile synthesis of flavonoid 7-O-glycosides. Journal of Organic Chemistry, 68, 6842–6845.
9.
LinA., ChangF., WuC., LiawC., WuY. (2005) New cytotoxic flavonoids from Thelypteris torresiana. Planta Medica, 71, 867–870.
10.
Morales-EscobarL., BracaA., PizzaC., De TommasiN. (2007) New phenolic derivatives from Vernonia mapirensis Gleason. ARKIVOC7, 349–358.
11.
BeagleyB.G., PritchardR.G., RamageR, and SouthwellI. (1982) A (+)-2-{(3R,6S,10R)-6,10-dimethylbicyclo[4.4.0]dec-1-en-3-yl}-2-propanol, rosifoliolActa Crystallographica, B38, 1391–1393.
12.
FujiokaT., KashiwadaY., KilkuskieR.E., CosentinoL.M., BallasL.M., JiangJ.B., JanzenW.P., ChenI.S., LeeK. (1994) Anti-AIDS agents, 11. Betulinic acid and platanic acid as antiHIV principles from Syzigium claviflorum, and the antiHIV activity of structurally related triterpenoids. Journal of Natural Products, 57, 243–247.
13.
BisioA., RomussiG., RussoE., CafaggiS., SchitoA. M., RepettoB., De TommasiN. (2008) Antimicrobial activity of the ornamental species Salvia corrugata, a potential new crop for extractive purposes. Journal of Agricultural and Food Chemistry, 56, 10468–10472.
14.
SuWen-C, FangJim-M, ChengYu-S. (1995) Sesquiterpenes from leaves of Cryptomeria japonica. Phytochemistry, 39, 603–607.
15.
BarreroA.F., ArteagaP., QuilezJ.F., RodriguezI., HerradorM.M. (1997) Sesquiterpene Glycosides and Phenylpropanoid Esters from Phonus arborescens (L.) G. Lopez (Carthamus arborescens L.). Journal of Natural Products, 60, 1026–1030.
